FDA Approves Emergency COVID-19 Antibody Treatment

The video discusses an experimental drug from Regeneron, which was administered to President Trump during his COVID-19 treatment. This medicine is designed for patients with mild to moderate symptoms who are at high risk of severe illness. Regeneron plans to provide initial doses for approximately 300,000 patients.

What new insight or understanding did you gain from this video?